Le Lézard
Classified in: Ebola virus, Health
Subject: SVY

Global Apheresis Equipment Industry



NEW YORK, Sept. 21, 2017 /PRNewswire/ -- This report analyzes the worldwide markets for Apheresis Equipment in US$ Thousand by the following Type of Apheresis Equipment: Equipment for Therapeutic Apheresis, and Equipment for Donor Apheresis.

Read the full report: https://www.reportlinker.com/p05112906



The Global market is additionally analyzed by the following Procedures: Photopheresis, Plasmapheresis, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World.

Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 14 companies including many key and niche players such as:
- Asahi Kasei Medical Co., Ltd.
- B Braun Melsungen AG
- Cerus Corporation
- Fresenius Kabi
- Haemonetics Corporation
- Kaneka Corporation



Read the full report: https://www.reportlinker.com/p05112906

APHERESIS EQUIPMENT MCP-1237 A GLOBAL STRATEGIC BUSINESS REPORT CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study


II. EXECUTIVE SUMMARY


1. INDUSTRY OVERVIEW
Apheresis Equipment - Rising Adoption of Therapeutic and Donor Apheresis Favors Growth
Donor Apheresis & Therapeutic Apheresis
Donor Apheresis: Dominating Equipment Sales
Table 1: Global Blood Donations by Region - Breakdown by Whole Blood Donations and Apheresis Donations for 2013 (includes corresponding Graph/Chart)
Table 2: Global Blood Donations - Apheresis Donation as % of Total Blood Donation by Geographic Region (includes corresponding Graph/Chart)
Therapeutic Apheresis to Witness Strong Growth
Disposable Apheresis Kits Market Benefits from Single-Use Nature of Products
Centrifugation Technology Continues to Lead, Membrane Filtration Promises Growth
Plasmapheresis Systems Dominate Apheresis Equipment Market
Neurology - The Major Application Area for Apheresis Equipment
Developed Markets Continue to Lead Apheresis Equipment Market
Developing Nations to Lead the Charge in Future
Rising Demand for Plasma from Biopharmaceutical Companies - Opportunity to Tap
Sustained Growth in Blood Collections Favors Apheresis Equipment Market
Table 3: Total Blood Collections (2016): Percentage Breakdown of Collections (Units) for Leukoreduced and Non-Leukoreduced Blood (includes corresponding Graph/Chart)
Competitive Landscape
Table 4: Leading Players in the Global Apheresis Systems Market (2016): Percentage Breakdown of Value Sales for Fresenius, Haemonetics, Terumo, and Others (includes corresponding Graph/Chart)
Table 5: Leading Players in the Global Blood Component Collection Market (2016): Percentage Breakdown of Value Sales for Fresenius/Fenwal, Haemonetics, Terumo Corp and Others (includes corresponding Graph/Chart)
Consolidation of Blood Collectors & Healthcare Providers Puts Pricing Pressure on Suppliers


2. KEY MARKET TRENDS & DRIVERS
Rising Cancer Incidence to Drive Volume of Apheresis Procedures
Table 6: Worldwide Incidence of Cancer (2010, 2020 & 2030): Number of New Cases Diagnosed (includes corresponding Graph/Chart)
Table 7: World Cancer Incidence (2012): Number of New Cancer Cases Reported (in Thousands) by Geographic Region and Gender (includes corresponding Graph/Chart)
Table 8: World Cancer Mortality (2012): Number of Cancer-Related Deaths (in Thousands) by Geographic Region and Gender (includes corresponding Graph/Chart)
Table 9: New Cancer Cases in the World by Affected Site (2012) (In Thousands) (includes corresponding Graph/Chart)
Technological Advancements and Novel Indications Augur Well for Apheresis Market
Blood Supply Shortage & Safety Concerns Bode Well for Apheresis Market
Photopheresis: A Popular Therapeutic Apheresis Procedure
Plasmapheresis Continues to Lead the Apheresis Market
Plateletpheresis Emerges as the 'Treatment of Choice'
Increase in Number of Platelet Donors Drives Apheresis Procedures
Pediatrics: An Unexplored Domain in Therapeutic Apheresis
Automated Blood Processing Systems in Open Heart Surgeries
CFA - An Effective Way to Pull Up Cold Hemagglutinin Disease
Improving Healthcare Expenditure to Drive Demand
Table 10: Healthcare Spending as % of GDP by Geographic Region (2016) (includes corresponding Graph/Chart)
Table 11: Per Capita Healthcare Spending (in $) in Select Developed Countries for the Year 2016 (includes corresponding Graph/Chart)
Aging Population: A Strong Growth Driver
Table 12: Global Aging Population in Select Regions/ Countries: Population of 60+ Individuals in '000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)
Table 13: Life Expectancy at Birth (in Years) in Select Countries for 2016 (includes corresponding Graph/Chart)
Key Challenges & Issues
Lack of Awareness among Patients Restrains Market Growth
Vendors' Attitude Hampers Growth Prospects of Therapeutic Apheresis
Development of Inexpensive Apheresis Therapies
Shortage of Qualified Donors
Challenges for Therapeutic Apheresis in the Unexplored Pediatrics Segment


3. TECHNOLOGY OVERVIEW
Apheresis - The Definition
Apheresis Vs Whole Blood Collection
Comparison of Apheresis and Whole Blood Collection
The Process of Apheresis - An Overview
Blood Components
Apheresis Procedure
Duration, Frequency, and Efficiency of Apheresis
Segregation of Blood Components
Centrifugation
Centrifugal Cell Separators
Filtration
Side Effects
Types of Apheresis Procedures
Plasmapheresis
Plasma Exchange and Plasmapheresis: The Difference
Therapeutic Plasma Exchange (TPE) or Plasma Exchange
TPE: Abnormal Components Removed from Blood
Plasmapheresis: Potential Uses Discovered in the Early Years
Potential Use of Plasmapheresis in Select Diseases Discovered in the Early Years
Erythrocytapheresis
Plateletpheresis
Leukapheresis
Photopheresis
Functioning of THERAKOStm - A Typical Photopheresis System
Lipidpheresis
Cytapheresis
Stem Cell Collection
Apheresis - A Review of Segmentation
Donor Apheresis
Process of Donor Apheresis
Automated Blood Donation Procedures
Safety of the Donor
Blood Components Required by Different Patients
Automated Apheresis
Therapeutic Apheresis: An Introduction
Therapeutic Apheresis Techniques
Applications of Therapeutic Apheresis
Categories of Indications for Therapeutic Apheresis
Therapeutic Apheresis is Remedial for Various Diseases
Indications for Therapeutic Apheresis
Type of Therapeutic Apheresis Procedure Used in Different Medication Conditions
Emerging Applications of Therapeutic Apheresis
Cost of Select Therapeutic Apheresis Procedures: An Overview


1. Photopheresis in GVHD (Graft-Versus-Host Disease)


2. Lipid Apheresis (LDL Apheresis)


3. Plasmapheresis and Other Procedures
Therapeutic Apheresis: What is the Risk Involved?
Replacement Fluid in Therapeutic Apheresis
Replacement Fluids Used in Therapeutic Apheresis
Various Replacement Fluids in Use
Select Replacement Fluids and their Limitations
Table 14: Fluid Balance in Fluid Replacement
Table 15: Volume Exchange of Plasma Constituents (includes corresponding Graph/Chart)
Table 16: Removal of IgM and IgG by Plasma Exchange Volume (includes corresponding Graph/Chart)
Table 17: Therapeutic Apheresis: Percentage Decrease and Restoration of Blood Components
Complications Involved and Suggested Treatment in the Therapeutic Apheresis Procedure
Therapeutic Plasmapheresis with Fresh Frozen Plasma (FFP) Replacement


4. BLOOD COMPONENTS & DERIVATIVES
Red Blood Cells (RBCs)
White Blood Cells (WBCs)
Platelets
Sources of Blood Plasma
Facts About Plasma and its Donation
Pre-requisites for Plasma Donors
The Complex Process of Becoming a Donor
Medical Screening
The Process of Plasma Donation
Select IQPP-authorized Plasma Collection Centers (US)
Ionic Composition of Blood
Types of Blood
General Facts about Blood
General Uses of Blood
Blood - Global Facts


5. PRODUCT INNOVATIONS/INTRODUCTIONS
Fresenius Introduces 6008 CAREsystem
Terumo BCT Launches Correct Connect System
FDA Approves IDE Supplement for Cerus' INTERCEPT Blood System
Health Canada Approves WBCD and PMN Cell Collection Protocols for Spectra Optia
USFDA Clears PMN Protocol for Terumo's Spectra Optia


6. RECENT INDUSTRY ACTIVITY
Haemonetics Gains FDA Approval for NexSys PCS Plasmapheresis System
Terumo BCT Receives CE Mark for Spectra Optia® Apheresis System
Terumo BCT Enters into Distribution Agreement with B Medical Systems
Mallinckrodt Takes Over Therakos
HemaCare Sells Therapeutic Apheresis Assets to Fresenius
Terumo BCT Files FDA Submission to Improve Blood Supply Safety
Fenwal Autopheresis-C Instruments Donated for Ebola Virus Study
Terumo opens Production Facility in Vietnam
Terumo Collaborates with Kaneka
Terumo to Distribute Therakos Products in Latin America
Terumo Enters Distribution Agreement with Therakos


7. FOCUS ON SELECT PLAYERS
Asahi Kasei Medical Co., Ltd. (Japan)
B Braun Melsungen AG (Germany)
Cerus Corporation (USA)
Fresenius Kabi (Germany)
Haemonetics Corporation (USA)
Kaneka Corporation (Japan)
Kawasumi Laboratories, Inc. (Japan)
Mallinckrodt Pharmaceuticals (Ireland)
Medica SpA (Italy)
NIKKISO Europe GmbH (Germany)
Terumo BCT, Inc. (USA)


8. GLOBAL MARKET PERSPECTIVE
Table 18: World Recent Past, Current & Future Analysis for Apheresis Equipment by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 19: World Historic Review for Apheresis Equipment by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 20: World 14-Year Perspective for Apheresis Equipment by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
Table 21: World Recent Past, Current & Future Analysis for Equipment for Therapeutic Apheresis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 22: World Historic Review for Equipment for Therapeutic Apheresis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 23: World 14-Year Perspective for Equipment for Therapeutic Apheresis by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
Table 24: World Recent Past, Current & Future Analysis for Equipment for Donor Apheresis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 25: World Historic Review for Equipment for Donor Apheresis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 26: World 14-Year Perspective for Equipment for Donor Apheresis by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
Table 27: World Recent Past, Current & Future Analysis for Apheresis Equipment by Procedure Type - Photopheresis, Plasmapheresis, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 28: World Historic Review for Apheresis Equipment by Procedure Type - Photopheresis, Plasmapheresis, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 29: World 14-Year Perspective for Apheresis Equipment by Procedure Type - Percentage Breakdown of Dollar Sales for Photopheresis, Plasmapheresis, and Others Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)


III. MARKET


1. THE UNITED STATES
A.Market Analysis
Apheresis Market - An Overview
Blood Donations
Table 30: Blood Donation in the US (2016): Percentage Breakdown of Number of Blood Donations by Type - Apheresis Donation and Whole Blood Donation (includes corresponding Graph/Chart)
Table 31: Blood Transfusions per 1000 population in the US (2012-2017) (includes corresponding Graph/Chart)
Blood Supply and Demand in the US - A Fact Sheet
Criteria for Platelet Donation
Criteria for Double Red Cell Donation
Plasma Donations
Table 32: Plasma Collection in the US for 2012, 2014 & 2016 (In Million Liters) (includes corresponding Graph/Chart)
Therapeutic Apheresis Registers Strong Growth
Table 33: US Market for Apheresis Equipment (2017): Percentage Breakdown of Revenues Generated Through Procedures by Therapeutic Area (includes corresponding Graph/Chart)
Competitive Scenario
Table 34: Leading Players in the US Whole Blood Collection Market (2016): Percentage Breakdown of Volume Sales for Fresenius, Haemonetics, Terumo and Others (includes corresponding Graph/Chart)
Table 35: Leading Players in the US Market for Therapeutic Apheresis in Neurological Disorders (2016): Percentage Breakdown of Revenues for Fresenius Kabi, Haemonetics, Terumo BCT, and Others (includes corresponding Graph/Chart)
Table 36: Leading Players in the US Market for Therapeutic Apheresis in Hematology and Oncology Disorders (2016): Percentage Breakdown of Revenues for Fresenius Kabi, Terumo BCT, and Others (includes corresponding Graph/Chart)
Consolidation of Blood Collectors and Healthcare Providers Puts Pricing Pressure on Suppliers
An Overview of Regulatory Environment and Reimbursement Scenario
Reimbursement Policies to Create Growth Opportunities for Therapeutic Apheresis
Medicaid Coverage for Therapeutic Apheresis by Various Conditions
Medicaid Coverage for Therapeutic Plasma Exchange
Table 37: Payment Rates for Apheresis Procedures in 2016 & 2017 (In US$) (includes corresponding Graph/Chart)
Product Launches
Strategic Corporate Developments
Select Players
B.Market Analytics
Table 38: US Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 39: US Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 40: US 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)


2. CANADA
A.Market Analysis
Outlook
Product Approval
B.Market Analytics
Table 41: Canadian Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 42: Canadian Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 43: Canadian 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)


3. JAPAN
A.Market Analysis
Outlook
Therapeutic Apheresis Market - An Overview
Growing Demand for Cancer Treatments Drives Plateletpheresis Market
Select Players
B.Market Analytics
Table 44: Japanese Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 45: Japanese Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 46: Japanese 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)


4. EUROPE
A.Market Analysis
Outlook
Blood Banks in Europe
Table 47: Leading Players in the European Whole Blood Collection Market (2016): Percentage Breakdown of Volume Sales for Fresenius, MacoPharma, Terumo and Others (includes corresponding Graph/Chart)
Strategic Corporate Development
B.Market Analytics
Table 48: European Recent Past, Current & Future Analysis for Apheresis Equipment by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 49: European Historic Review for Apheresis Equipment by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 50: European 14-Year Perspective for Apheresis Equipment by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
Table 51: European Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 52: European Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 53: European 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4a. FRANCE
Market Analysis
Table 54: French Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 55: French Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 56: French 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4b. GERMANY
A.Market Analysis
Outlook
Product Launch
Select Players
B.Market Analytics
Table 57: German Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 58: German Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 59: German 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4c. ITALY
A.Market Analysis
Outlook
Medica SpA - A Select Player
B.Market Analytics
Table 60: Italian Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 61: Italian Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 62: Italian 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM
Market Analysis
Table 63: UK Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 64: UK Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 65: UK 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4e. SPAIN
Market Analysis
Table 66: Spanish Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 67: Spanish Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 68: Spanish 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4f. REST OF EUROPE
A.Market Analysis
Outlook
Mallinckrodt Pharmaceuticals (Ireland) - A Key Player
B.Market Analytics
Table 69: Rest of Europe Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 70: Rest of Europe Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 71: Rest of Europe 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)


5. ASIA-PACIFIC
Market Analysis
Table 72: Asia-Pacific Recent Past, Current & Future Analysis for Apheresis Equipment by Geographic Region - Australia, China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 73: Asia-Pacific Historic Review for Apheresis Equipment by Geographic Region - Australia, China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 74: Asia-Pacific 14-Year Perspective for Apheresis Equipment by Geographic Region - Percentage Breakdown of Dollar Sales for Australia, China and Rest of Asia-Pacific Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)
Table 75: Asia-Pacific Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 76: Asia-Pacific Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 77: Asia-Pacific 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

5a. AUSTRALIA
A.Market Analysis
Outlook
Strategic Corporate Development
B.Market Analytics
Table 78: Australian Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 79: Australian Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 80: Australian 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

5b. CHINA
Market Analysis
Table 81: Chinese Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 82: Chinese Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 83: Chinese 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

5c. REST OF ASIA-PACIFIC
A.Market Analysis
Outlook
Strategic Corporate Development
B.Market Analytics
Table 84: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 85: Rest of Asia-Pacific Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 86: Rest of Asia-Pacific 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)


6. REST OF WORLD
A.Market Analysis
Outlook
Strategic Corporate Developments
B.Market Analytics
Table 87: Rest of World Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
Table 88: Rest of World Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
Table 89: Rest of World 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)


IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 14 (including Divisions/Subsidiaries - 20) The United States (8) Japan (3) Europe (9) - Germany (5) - Italy (3) - Rest of Europe (1)
Read the full report: https://www.reportlinker.com/p05112906

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

https://www.reportlinker.com


__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

23 oct 2017
KENILWORTH, N.J., Oct. 23, 2017 /PRNewswire/ --As patients get older, the number of doctors they see and amount of office visits they have increase significantly. In fact, adults aged 65 and over visit the doctor more than twice as often as younger...

20 oct 2017
STOCKHOLM, Oct. 20, 2017 /PRNewswire/ -- THIRD QUARTER HIGHLIGHTS Reported sales decreased by -6% YoY. Sales adjusted for comparable units and currency declined by -3%. Networks sales declined by -4% YoY. Sales adjusted for comparable units,...

20 oct 2017
GÖTEBORG, Sweden, Oct. 20, 2017 /PRNewswire/ -- "In the third quarter both the Volvo Group's sales and profitability continued to increase, with an especially strong performance in our construction equipment business. The quarter was also...

19 oct 2017
WATERTOWN, Mass., Oct. 19, 2017 /PRNewswire/ -- Bright Horizons Family Solutions® Inc. (NYSE: BFAM) will release results for the quarter ended September 30, 2017, on Wednesday, November 1, 2017, after the stock market closes. Following the release,...

18 oct 2017
SPRINGFIELD, Mass. and JOHANNESBURG, Oct. 18, 2017 /PRNewswire/ -- SystemOne, the leader in global disease intelligence for rapid detection and response, recently announced that its GxAlert software is now configured to transmit HCV data for...

17 oct 2017
SHELTON, Conn., Oct. 17, 2017 /PRNewswire/ -- NanoViricides, Inc. (NYSE American: NNVC) (the "Company") will present the results of its anti-herpes nanoviricide treatment for Viral Acute Retinal Necrosis (vARN) at the 2017 Annual meeting of the...




News published on 21 september 2017 at 15:42 and distributed by: